Ayşegül Aksan (A Aksan, Aysegül Aksan)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Venues

Diagnostics (Basel, Switzerland)

Alimentary pharmacology & therapeutics

Nutrients

Scandinavian journal of gastroenterology

Interdisciplinary Crohn Colitis Centre

Hacettepe Üniversitesi (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Interdisciplinary Crohn Colitis Centre

Germany

Researcher

Hacettepe Üniversitesi Apr 25 2011 - Feb 01 2019

Turkey

Research Assistant :: Nutrition and Dietetics

Education History

Hacettepe Üniversitesi

Turkey

PHD :: Nutrition and Dietetics

Hacettepe Üniversitesi

Turkey

MSC :: Nutrition and Dietetics

Publications

Karima Farrag, Ayşegül Aksan, Valëza Ademaj-Kospiri, Eleni Leventi, Jürgen Michael Stein
Use of Biomarkers of Inflammation in the Differentiation of Iron Deficiency and Anaemia-Lessons from Inflammatory Bowel Disease. Diagnostics (Basel, Switzerland) 14 (14) (2024)
Ana Luísa Falcomer, Claudia B Pratesi, Eduardo Yoshio Nakano, Cláudia Balula Chaves, Mohammad Rostami-Nejad, Morad Guennouni, Ayşegül Aksan, Jacques Pouchot, Winfried Häuser, Renata Puppin Zandonadi
From Struggle to Strength: A Multicentric Study on How Public Policies for Celiac Disease Transform Lives. Nutrients 16 (17) (2024)
Karima Farrag, Ayşegül Aksan, Valëza Ademaj-Kospiri, Eleni Leventi, Jürgen Michael Stein
Use of Biomarkers of Inflammation in the Differentiation of Iron Deficiency and Anaemia-Lessons from Inflammatory Bowel Disease. Diagnostics (Basel, Switzerland) 14 (14) (2024)
Karima Farrag, Ayşegül Aksan, Valëza Ademaj-Kospiri, Eleni Leventi, Jürgen Michael Stein
Use of Biomarkers of Inflammation in the Differentiation of Iron Deficiency and Anaemia-Lessons from Inflammatory Bowel Disease. Diagnostics (Basel, Switzerland) 14 (14) (2024)
Johanna Erbach, Florian Bonn, Max Diesner, Anne Arnold, Jürgen Michael Stein, Oliver Schröder, Ayşegül Aksan
Relevance of Biotin Deficiency in Patients with Inflammatory Bowel Disease and Utility of Serum 3 Hydroxyisovaleryl Carnitine as a Practical Everyday Marker. Journal of clinical medicine 11 (4) (2022)
Ayşegül Aksan, Axel U Dignass, Jürgen Michael Stein
Letter to the editor: in response to: Richard F Pollock & Patrick Biggar. Indirect methods of comparison of the safety of ferric derisomaltose, iron sucrose and ferric carboxymaltose in the treatment of iron deficiency anemia. Expert review of hematology (2021)
Ayşegül Aksan, Izzet Erdal, Siddika Songül Yalcin, Jürgen Michael Stein, Gülhan Samur
Osteopontin Levels in Human Milk Are Related to Maternal Nutrition and Infant Health and Growth. Nutrients 13 (8) (2021)
Eleni Leventi, Ayşegül Aksan, Carl Thomas Nebe, Jürgen Michael Stein, Karima Farrag
Zinc Protoporphyrin Is a Reliable Marker of Functional Iron Deficiency in Patients with Inflammatory Bowel Disease. Diagnostics (Basel, Switzerland) 11 (2) (2021)
Ayşegül Aksan, Axel U Dignass, Jürgen Michael Stein
Letter: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark. Advances in therapy 36 (8) (2019)
Ayşegül Aksan, Karima Farrag, Jürgen Michael Stein
An update on the evaluation and management of iron deficiency anemia in inflammatory bowel disease. Expert review of gastroenterology & hepatology 13 (2) (2018)
Jürgen Michael Stein, Andreas Walper, Wolfgang Klemm, Karima Farrag, Ayşegül Aksan, Axel U Dignass
Safety and efficacy of intravenous iron isomaltoside for correction of anaemia in patients with inflammatory bowel disease in everyday clinical practice. Scandinavian journal of gastroenterology 53 (9) (2018)
Ayşegül Aksan, H Işık, Heinfried H Radeke, Axel U Dignass, Jürgen Michael Stein
Systematic review with network meta-analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 45 (10) (2017)
Jürgen Michael Stein, Ayşegül Aksan, Karima Farrag, Axel U Dignass, Heinfried H Radeke
Management of inflammatory bowel disease-related anemia and iron deficiency with specific reference to the role of intravenous iron in current practice. Expert opinion on pharmacotherapy 18 (16) (2017)
Ayşegül Aksan, H Işık, Heinfried H Radeke, Axel U Dignass, Jürgen Michael Stein
Editorial: which iron preparation for patients with IBD? Authors' reply. Alimentary pharmacology & therapeutics 46 (2) (2017)
Ayşegül Aksan, H Işık, Heinfried H Radeke, Axel U Dignass, Jürgen Michael Stein
Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapies-authors' reply. Alimentary pharmacology & therapeutics 46 (7) (2017)
Ayşegül Aksan, H Işık, Heinfried H Radeke, Axel U Dignass, Jürgen Michael Stein
Letter: inconsistency in reporting of hypophosphataemia after intravenous iron-authors' reply. Alimentary pharmacology & therapeutics 46 (6) (2017)

Ayşegül Aksan.css-eqlu8i{font-size:small;padding-left:4px;} (A Aksan, Aysegül Aksan)

Publication Activity (10 Years)

Top Topics

Top Venues

Ayşegül Aksan (A Aksan, Aysegül Aksan)